Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients

Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients

Saved in:
Bibliographic Details
Published in:Transplantation proceedings Vol. 29; no. 7; pp. 2955 - 2957
Main Authors: Kliem, V., Schaumann, D., Ehlerding, G., Eberhard, O.K., Lufft, V., Schlitt, H.J., Pichlmayr, R., Koch, K.M., Brunkhorst, R.
Format: Journal Article Conference Proceeding
Language:English
Published: New York, NY Elsevier Inc 01-11-1997
Elsevier Science
Subjects:
Adult
Biological and medical sciences
Drug Resistance
Drug Therapy, Combination
Female
Follow-Up Studies
Graft Rejection - drug therapy
Humans
Immunomodulators
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Kidney Transplantation - immunology
Male
Medical sciences
Muromonab-CD3 - therapeutic use
Pharmacology. Drug treatments
Tacrolimus - adverse effects
Tacrolimus - therapeutic use
Time Factors
Human
Rejection
Corticosteroid
Tacrolimus
Surgery
Transplantation
Homotransplantation
Long term
Negative therapeutic reaction
Drug switching
Kidney
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(97)00743-4